Portal de Periódicos da CAPES

HUMAN INTERNAL MAMMARY ARTERY RESPONSES TO NON‐PEPTIDE VASOPRESSIN ANTAGONISTS

1994; Wiley; Volume: 21; Issue: 2 Linguagem: Inglês

10.1111/j.1440-1681.1994.tb02478.x

1440-1681

James J. Liu, Paddy A. Phillips, Louise M. Burrell, Brian Buxton, Colin I. Johnston,

Electrolyte and hormonal disorders

SUMMARY 1. OPC‐21268 and OPC‐31260 are newly developed orally active non‐peptide vasopressin (AVP) V 1 and V 2 receptor antagonists, respectively. The effects of the two compounds on human vessels have not been studied. 2. The effects of the two compounds on AVP‐induced contraction of human internal mammary arteries (IMA) were investigated. Their effects were compared with the peptide V 1 and V 2 antagonists d(CH 2 ) s Sar 7 AVP (SAVP) and d(CH 2 ) 5 D‐Ileu 2 11eu 4 AVP (Ileu 2 Ileu 4 AVP), respectively. 3. The V 1 antagonist OPC‐21268 failed to antagonize AVP‐induced contraction at low concentrations and potentiated the contraction at higher concentration (3 × 10 − ‐ 7 mol/L, P<0.05). It also caused a mild direct contractile effect on IMA. In contrast, the peptide V 1 antagonist SAVP potently inhibited the AVP‐induced contraction, indicating that functionally constrictor V 1 receptors exist in IMA. Both the nonpeptide and peptide V 2 antagonists OPC‐31260 (3X10 − ‐ 6 mol/L) and Ileu 2 Ileu 4 AVP significantly antagonized the AVP‐induced contraction (P<0.01). 4. The AVP‐induced contraction was reversed by high concentrations of OPC‐31260 (10 − ‐ 6 mol/L‐3×10 − ‐ 5 mol/L) but not by OPC‐21268 (up to 3X 10 − ‐ 5 mol/L). 5. These studies indicate that, in human IMA, OPC‐21268 is a partial VI receptor agonist with no V 1 receptor antagonist activity, while OPC‐31260 is a V1 receptor antagonist. The results also indicate that Ileu 2 Ileu 4 AVP may be a V l receptor antagonist in humans.